Sinphar Pharmaceutical Co (TPE:1734) E10: NT$0.71 (As of Dec. 2025)


TPE:1734 Sinphar Pharmaceutical Co Ltd TPE:1734
81 GF Score
Price NT$32.70
GF Value NT$33.13
Valuation Fairly Valued
! 1 Warning Sign
View Full Analysis

What is Sinphar Pharmaceutical Co E10?

Sinphar Pharmaceutical Co TPE:1734 -1.08% 81 E10 is NT$0.71 as of Dec. 2025. GuruFocus rates TPE:1734 with a GF Score™ of 81/100 and a GF Value™ of NT$33.13 (Fairly Valued). The stock has 1 warning sign investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Sinphar Pharmaceutical Co's adjusted earnings per share data for the three months ended in Dec. 2025 was NT$0.530. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is NT$0.71 for the trailing ten years ended in Dec. 2025.

During the past 12 months, Sinphar Pharmaceutical Co's average E10 Growth Rate was 39.20% per year. During the past 3 years, the average E10 Growth Rate was 17.30% per year. During the past 5 years, the average E10 Growth Rate was 10.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Sinphar Pharmaceutical Co was 17.30% per year. The lowest was -4.80% per year. And the median was 6.30% per year.

As of today (2026-06-29), Sinphar Pharmaceutical Co's current stock price is NT$32.70. Sinphar Pharmaceutical Co's E10 for the quarter that ended in Dec. 2025 was NT$0.71. Sinphar Pharmaceutical Co's Shiller PE Ratio of today is 46.06.

During the past 13 years, the highest Shiller PE Ratio of Sinphar Pharmaceutical Co was 122.17. The lowest was 25.94. And the median was 61.58.


Sinphar Pharmaceutical Co  (TPE:1734) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Sinphar Pharmaceutical Co's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=32.70/0.71
=46.06

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Sinphar Pharmaceutical Co was 122.17. The lowest was 25.94. And the median was 61.58.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Sinphar Pharmaceutical Co E10 Related Terms


Sinphar Pharmaceutical Co E10 Historical Data

* Premium members only.

The historical data trend for Sinphar Pharmaceutical Co's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sinphar Pharmaceutical Co E10 Chart

Sinphar Pharmaceutical Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.38 0.44 0.45 0.51 0.71

Sinphar Pharmaceutical Co Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.51 0.60 0.64 0.70 0.71

TPE:1734 vs VRTX, REGN, ALNY: E10 Comparison

For the Biotechnology subindustry, Sinphar Pharmaceutical Co's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sinphar Pharmaceutical Co Shiller PE Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Sinphar Pharmaceutical Co's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Sinphar Pharmaceutical Co's Shiller PE Ratio falls into.


TPE:1734
81GF Score
Sinphar Pharmaceutical Co Ltd TPE:1734
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sinphar Pharmaceutical Co E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Sinphar Pharmaceutical Co's adjusted earnings per share data for the three months ended in Dec. 2025 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Dec. 2025 (Change)*Current CPI (Dec. 2025)
=0.53/324.0540*324.0540
=0.530

Current CPI (Dec. 2025) = 324.0540.

Sinphar Pharmaceutical Co Quarterly Data

per share eps CPI Adj_EPS
201603 -0.088 238.132 -0.120
201606 -0.009 241.018 -0.012
201609 -0.035 241.428 -0.047
201612 0.219 241.432 0.294
201703 -0.044 243.801 -0.058
201706 0.053 244.955 0.070
201709 0.071 246.819 0.093
201712 0.115 246.524 0.151
201803 0.088 249.554 0.114
201806 -0.009 251.989 -0.012
201809 -0.079 252.439 -0.101
201812 0.035 251.233 0.045
201903 0.079 254.202 0.101
201906 -0.132 256.143 -0.167
201909 -0.053 256.759 -0.067
201912 0.176 256.974 0.222
202003 0.141 258.115 0.177
202006 0.044 257.797 0.055
202009 -0.053 260.280 -0.066
202012 -0.282 260.474 -0.351
202103 0.026 264.877 0.032
202106 0.026 271.696 0.031
202109 -0.176 274.310 -0.208
202112 -0.079 278.802 -0.092
202203 0.309 287.504 0.348
202206 0.459 296.311 0.502
202209 0.362 296.808 0.395
202212 0.062 296.797 0.068
202303 0.423 301.836 0.454
202306 0.573 305.109 0.609
202309 0.400 307.789 0.421
202312 0.581 306.746 0.614
202403 0.581 312.332 0.603
202406 0.343 314.175 0.354
202409 0.250 315.301 0.257
202412 0.430 315.605 0.442
202503 0.590 319.799 0.598
202506 0.362 322.561 0.364
202509 0.440 324.800 0.439
202512 0.530 324.054 0.530

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of NT$0.71 mean?
Sinphar Pharmaceutical Co (TPE:1734) has a E10 of NT$0.71 as of Dec. 2025. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Sinphar Pharmaceutical Co and its competitors.
Is Sinphar Pharmaceutical Co's E10 too high?
Sinphar Pharmaceutical Co's current E10 is NT$0.71. Overall, Sinphar Pharmaceutical Co has a GF Score™ of 81/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Sinphar Pharmaceutical Co's E10 compare to VRTX and REGN?
Sinphar Pharmaceutical Co's E10 of NT$0.71 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Biotechnology company?
A good E10 depends on the Biotechnology industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Sinphar Pharmaceutical Co and its competitors. Sinphar Pharmaceutical Co's current E10 is NT$0.71. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sinphar Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Sinphar Pharmaceutical Co (TPE:1734) is currently considered Fairly Valued. The stock's GF Value™ is NT$33.13, compared to a current price of NT$32.70 — trading 1.3% below its estimated fair value. The current E10 is NT$0.71. Sinphar Pharmaceutical Co's overall GF Score™ is 81/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For Sinphar Pharmaceutical Co (TPE:1734), the current E10 is NT$0.71 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Sinphar Pharmaceutical Co (TPE:1734) Overvalued in 2026?

Based on GuruFocus' analysis, Sinphar Pharmaceutical Co stock appears to be undervalued. The current stock price of NT$32.70 is trading 1.3% below its estimated GF Value™ of NT$33.13. GuruFocus considers Sinphar Pharmaceutical Co to be Fairly Valued.

Key valuation signals for TPE:1734:

  • E10: NT$0.71
  • GF Value™: NT$33.13 vs. price of NT$32.70 (1.3% below fair value)
  • GF Score™: 81/100 with 1 warning sign

No single metric tells the full story. See the TPE:1734 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Sinphar Pharmaceutical Co Business Description

Address No.84, Zhongshan Road, Dongshan Township, Zhongshan Village, Yilan, TWN, 269
Sinphar Pharmaceutical Co Ltd operates in the pharmaceutical segment. The company mainly engages in the production, processing, and trading of various Chinese medicines, medicinal cosmetics, and nutrients. The company's reportable segments are; Pharmaceuticals which derives key revenue, Healthy food, and others. Geographically, the company generates a majority of its revenue from Taiwan and the rest from China, Vietnam, Indonesia, America, and other regions.
81GF Score

Get the complete analysis for TPE:1734

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$32.70
Price
NT$33.13
GF Value